- Home
- SILC vs MGX Comparison
SILC vs MGX Comparison
Compare SILC & MGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILC
- MGX
- Stock Information
- Founded
- SILC 1987
- MGX 2018
- Country
- SILC Israel
- MGX United States
- Employees
- SILC N/A
- MGX N/A
- Industry
- SILC Computer Manufacturing
- MGX
- Sector
- SILC Technology
- MGX
- Exchange
- SILC Nasdaq
- MGX NYSE
- Market Cap
- SILC 83.4M
- MGX 70.4M
- IPO Year
- SILC 1994
- MGX 2024
- Fundamental
- Price
- SILC $15.10
- MGX $3.55
- Analyst Decision
- SILC Hold
- MGX Strong Buy
- Analyst Count
- SILC 1
- MGX 7
- Target Price
- SILC N/A
- MGX $16.67
- AVG Volume (30 Days)
- SILC 47.3K
- MGX 4.5M
- Earning Date
- SILC 01-30-2025
- MGX 02-12-2025
- Dividend Yield
- SILC N/A
- MGX N/A
- EPS Growth
- SILC N/A
- MGX N/A
- EPS
- SILC N/A
- MGX N/A
- Revenue
- SILC $62,386,000.00
- MGX $55,080,000.00
- Revenue This Year
- SILC N/A
- MGX $11.59
- Revenue Next Year
- SILC $4.15
- MGX N/A
- P/E Ratio
- SILC N/A
- MGX N/A
- Revenue Growth
- SILC N/A
- MGX 45.13
- 52 Week Low
- SILC $11.35
- MGX $1.61
- 52 Week High
- SILC $19.04
- MGX $12.74
- Technical
- Relative Strength Index (RSI)
- SILC 60.13
- MGX 64.37
- Support Level
- SILC $13.52
- MGX $2.91
- Resistance Level
- SILC $15.23
- MGX $3.63
- Average True Range (ATR)
- SILC 0.83
- MGX 0.54
- MACD
- SILC 0.14
- MGX 0.09
- Stochastic Oscillator
- SILC 96.26
- MGX 55.66
About SILC Silicom Ltd
Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters; Edge Networking Solutions; FPGA Based Cards; x86 Open Appliances Bypass Switches and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).